Retinal laser burn-induced neuropathy leads to substance P-dependent loss of ocular immune privilege

Journal of Immunology

Volumn 189, Issue 3, 2012, Pages 1237-1242

  Lucas, Kenyatta ^a   Karamichos, Dimitris ^a   Mathew, Rose ^a   Zieske, James D ^a   Stein Streilein, Joan ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; SPANTIDE I; SPANTIDE II; SUBSTANCE P; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR CHAMBER ASSOCIATED IMMUNE DEVIATION; ARTICLE; AUTOCRINE EFFECT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; EYE INFLAMMATION; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; KNOCKOUT MOUSE; MOUSE; NEUROPATHY; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS INHIBITION; RETINA INJURY; RETINA LASER BURN; SIGNAL TRANSDUCTION;

ANIMALS; EYE BURNS; FEMALE; HOMEOSTASIS; LASERS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; RETINA; SUBSTANCE P;

EID: 84864139444     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103264     Document Type: Article

References (42)

1. Qiao, H., K. Lucas, and J. Stein-Streilein. 2009. Retinal laser burn disrupts immune privilege in the eye. Am. J. Pathol. 174: 414-422.
2. Taylor, A. W. 2002-2003. Neuroimmunomodulation and immune privilege: the role of neuropeptides in ocular immunosuppression. Neuroimmunomodulation 10: 189-198. (Pubitemid 36205295)
3. Maggi, C. A. 1997. The effects of tachykinins on inflammatory and immune cells. Regul. Pept. 70: 75-90. (Pubitemid 27362298)
4. O'Connor, T. M., J. O'Connell, D. I. O'Brien, T. Goode, C. P. Bredin, and F. Shanahan. 2004. The role of substance P in inflammatory disease. J. Cell. Physiol. 201: 167-180. (Pubitemid 39305095)
5. Douglas, S. D., J. P. Lai, F. Tuluc, L. Schwartz, and L. E. Kilpatrick. 2008. Neurokinin-1 receptor expression and function in human macrophages and brain: perspective on the role in HIV neuropathogenesis. Ann. N. Y. Acad. Sci. 1144: 90-96.
6. Sio, S. W., M. K. Puthia, J. Lu, S. Moochhala, and M. Bhatia. 2008. The neuropeptide substance P is a critical mediator of burn-induced acute lung injury. J. Immunol. 180: 8333-8341.
7. Arsenescu, R., A. M. Blum, A. Metwali, D. E. Elliott, and J. V. Weinstock. 2005. IL-12 induction of mRNA encoding substance P in murine macrophages from the spleen and sites of inflammation. J. Immunol. 174: 3906-3911. (Pubitemid 40395963)
8. Lotz, M., J. H. Vaughan, and D. A. Carson. 1988. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 241: 1218-1221.
9. Tervo, T., K. Tervo, and L. Eränkö. 1982. Ocular neuropeptides. Med. Biol. 60: 53-60. (Pubitemid 12017127)
10. Streilein, J. W. 2003. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat. Rev. Immunol. 3: 879-889. (Pubitemid 37411717)
11. Medawar, P. B. 1948. Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br. J. Exp. Pathol. 29: 58-69.
12. Li, J. H., D. Rosen, P. Sondel, and G. Berke. 2002. Immune privilege and FasL: two ways to inactivate effector cytotoxic T lymphocytes by FasL-expressing cells. Immunology 105: 267-277. (Pubitemid 34304403)
13. Streilein, J. W., K. Ohta, J. S. Mo, and A. W. Taylor. 2002. Ocular immune privilege and the impact of intraocular inflammation. DNA Cell Biol. 21: 453-459. (Pubitemid 35034588)
14. Suter, T., G. Biollaz, D. Gatto, L. Bernasconi, T. Herren, W. Reith, and A. Fontana. 2003. The brain as an immune privileged site: dendritic cells of the central nervous system inhibit T cell activation. Eur. J. Immunol. 33: 2998-3006. (Pubitemid 37428332)
15. Li, X., S. Taylor, B. Zegarelli, S. Shen, J. O'Rourke, and R. E. Cone. 2004. The induction of splenic suppressor T cells through an immune-privileged site requires an intact sympathetic nervous system. J. Neuroimmunol. 153: 40-49. (Pubitemid 38950926)
16. Dai, Z., I. W. Nasr, M. Reel, S. Deng, L. Diggs, C. P. Larsen, D. M. Rothstein, and F. G. Lakkis. 2005. Impaired recall of CD8 memory T cells in immunologically privileged tissue. J. Immunol. 174: 1165-1170.
17. Sonoda, K. H., T. Sakamoto, H. Qiao, T. Hisatomi, T. Oshima, C. Tsutsumi-Miyahara, M. Exley, S. P. Balk, M. Taniguchi, and T. Ishibashi. 2005. The analysis of systemic tolerance elicited by antigen inoculation into the vitreous cavity: vitreous cavity-associated immune deviation. Immunology 116: 390-399. (Pubitemid 41532130)
18. Faunce, D. E., K.-H. Sonoda, and J. Stein-Streilein. 2001. MIP-2 recruits NKT cells to the spleen during tolerance induction. J. Immunol. 166: 313-321. (Pubitemid 32038447)
19. Sugita, S., Y. Usui, S. Horie, Y. Futagami, H. Aburatani, T. Okazaki, T. Honjo, M. Takeuchi, and M. Mochizuki. 2009. T-cell suppression by programmed cell death 1 ligand 1 on retinal pigment epithelium during inflammatory conditions. Invest. Ophthalmol. Vis. Sci. 50: 2862-2870.
20. Sugita, S., S. Horie, O. Nakamura, K. Maruyama, H. Takase, Y. Usui, M. Takeuchi, K. Ishidoh, M. Koike, Y. Uchiyama, et al. 2009. Acquisition of T regulatory function in cathepsin L-inhibited T cells by eye-derived CTLA-2α during inflammatory conditions. J. Immunol. 183: 5013-5022.
21. Zamiri, P., S. Sugita, and J. W. Streilein. 2007. Immunosuppressive properties of the pigmented epithelial cells and the subretinal space. Chem. Immunol. Allergy 92: 86-93. (Pubitemid 47096898)
22. Ishida, K., N. Panjwani, Z. Cao, and J. W. Streilein. 2003. Participation of pigment epithelium in ocular immune privilege. 3. Epithelia cultured from iris, ciliary body, and retina suppress T-cell activation by partially non-overlapping mechanisms. Ocul. Immunol. Inflamm. 11: 91-105. (Pubitemid 37088581)
23. Wilbanks, G. A., and J. W. Streilein. 1992. Macrophages capable of inducing anterior chamber associated immune deviation demonstrate spleen-seeking migratory properties. Reg. Immunol. 4: 130-137.
24. Taylor, A. W. 2009. Neuropeptides, aqueous humor, and ocular immune privilege. In Neuropeptides in the Eye. J. Troger, G. Kieslbach, and N. Bechrakis, eds. Research Signpost, Kerala, India, p. 79-91.
25. Crane, I. J., and J. Liversidge. 2008. Mechanisms of leukocyte migration across the blood-retina barrier. Semin. Immunopathol. 30: 165-177.
26. Stein-Streilein, J., and J. W. Streilein. 2002. Anterior chamber associated immune deviation (ACAID): regulation, biological relevance, and implications for therapy. Int. Rev. Immunol. 21: 123-152. (Pubitemid 34791937)
27. Stein-Streilein, J. 2008. Immune regulation and the eye. Trends Immunol. 29: 503-586.
28. Mo, J. S., and J.W. Streilein. 2001. Immune privilege persists in eyes with extreme inflammation induced by intravitreal LPS. Eur. J. Immunol. 31: 3806-3815. (Pubitemid 34030995)
29. Ohta, K., B. Wiggert, A. W. Taylor, and J. W. Streilein. 1999. Effects of experimental ocular inflammation on ocular immune privilege. Invest. Ophthalmol. Vis. Sci. 40: 2010-2018. (Pubitemid 29365164)
30. Casini, G., D. W. Rickman, C. Sternini, and N. C. Brecha. 1997. Neurokinin 1 receptor expression in the rat retina. J. Comp. Neurol. 389: 496-507. (Pubitemid 28353910)
31. Catalani, E., C. Gangitano, L. Bosco, and G. Casini. 2004. Expression of the neurokinin 1 receptor in the mouse retina. Neuroscience 128: 519-530. (Pubitemid 39277422)
32. Ansel, J. C., J. R. Brown, D. G. Payan, and M. A. Brown. 1993. Substance P selectively activates TNF-alpha gene expression in murine mast cells. J. Immunol. 150: 4478-4485. (Pubitemid 23133724)
33. Matsas, R., A. J. Kenny, and A. J. Turner. 1984. The metabolism of neuropeptides: the hydrolysis of peptides, including enkephalins, tachykinins and their analogues, by endopeptidase-24.11. Biochem. J. 223: 433-440. (Pubitemid 14023015)
34. Folkers, K., R. Håkanson, J. Hörig, J. C. Xu, and S. Leander. 1984. Biological evaluation of substance P antagonists. Br. J. Pharmacol. 83: 449-456. (Pubitemid 14012649)
35. Ohta, K., S. Yamagami, A. W. Taylor, and J. W. Streilein. 2000. IL-6 antagonizes TGF-β and abolishes immune privilege in eyes with endotoxin-induced uveitis. Invest. Ophthalmol. Vis. Sci. 41: 2591-2599. (Pubitemid 30624387)
36. Streilein, J. W., and S. W. Cousins. 1990. Aqueous humor factors and their effect on the immune response in the anterior chamber. Curr. Eye Res. 9(Suppl): 175-182. (Pubitemid 20295620)
37. Taylor, A. W., J. W. Streilein, and S. W. Cousins. 1994. Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor. J. Immunol. 153: 1080-1086. (Pubitemid 24228499)
38. Ferguson, T. A., S. Fletcher, J. Herndon, and T. S. Griffith. 1995. Neuropeptides modulate immune deviation induced via the anterior chamber of the eye. J. Immunol. 155: 1746-1756.
39. Jegliński, W., D. Koczyk, M. Zaremba, and B. Oderfeld-Nowak. 1995. Bilateral gliosis in unilaterally lesioned septohippocampal system: changes in GFAP immunoreactivity and content. J. Neurosci. Res. 41: 394-402.
40. Decaris, E., C. Guingamp, M. Chat, L. Philippe, J. P. Grillasca, A. Abid, A. Minn, P. Gillet, P. Netter, and B. Terlain. 1999. Evidence for neurogenic transmission inducing degenerative cartilage damage distant from local inflammation. Arthritis Rheum. 42: 1951-1960. (Pubitemid 30257762)
41. Donkin, J. J., R. J. Turner, I. Hassan, and R. Vink. 2007. Substance P in traumatic brain injury. Prog. Brain Res. 161: 97-109. (Pubitemid 47017400)
42. Stjernschantz, J., M. Sears, and H. Mishima. 1982. Role of substance P in the antidromic vasodilation, neurogenic plasma extravasation and disruption of the blood-aqueous barrier in the rabbit eye. Naunyn Schmiedebergs Arch. Pharmacol. 321: 329-335. (Pubitemid 13185765)